HB219, the Improving Menopause Care for Veterans Act of 2025, would require the Comptroller General to study how the Department of Veterans Affairs provides menopause-related care to veterans, including care for perimenopause, genitourinary syndrome of menopause, and menopause. The study would examine VA training and clinical protocols, diagnosis and treatment practices, referrals to non-VA providers, access to interdisciplinary care, outreach and education efforts, quality of care, veteran feedback, complaint-resolution mechanisms, and the extent to which VA uses research to improve treatment and develop new protocols.
The bill also requires a public report within 18 months of enactment that includes findings and recommendations for improving VA menopause care. After the report is issued, the Secretary of Veterans Affairs must submit a strategic plan within six months describing how the department will implement the recommendations and improve both the quality and access of menopause care under existing VA care authorities in title 38.
Impact
HB219 would not directly create a new benefit or mandate a specific treatment standard, but it would impose a federal oversight and reporting requirement on the Department of Veterans Affairs. It specifically focuses on medical services furnished under sections 1703 and 1710 of title 38, which govern VA care and community care, and would likely prompt review of VA clinical guidance, provider training, referral practices, and veteran outreach related to menopause. The bill could affect veterans experiencing menopause-related conditions and may influence how VA allocates resources, develops protocols, and coordinates care with outside providers.
Sentiment
The available context suggests generally favorable sentiment toward the bill, as it was introduced by multiple House members and advanced to the Subcommittee on Health without any recorded votes or public opposition in the provided materials. The bill’s framing as a study and strategic planning measure, rather than a direct spending or entitlement expansion, may also make it more broadly acceptable. No committee transcript is available, so there is no recorded debate in the supplied record.
Contention
No specific points of contention are documented in the provided materials. Potential areas of debate, based on the bill’s structure, could include whether the VA already has sufficient menopause-care protocols, whether a study is the best use of resources, and how quickly the department could implement recommendations. Another possible issue is the scope of care covered, including the balance between VA-provided services and referrals to non-VA providers under existing authorities.
A resolution expressing support for the recognition of October 2025 as "World Menopause Awareness Month," and expressing the sense of the Senate regarding global awareness and access to care during the menopausal transition and post-menopause.
Designates October of each year as "Menopause Awareness Month" October 11 of each year as "Perimenopause Day," and October 18 of each year as "Postmenopause Day" in New Jersey.
Establishes interagency council on menopause in DOH and requires certain lincensed health care professionals to distribute menopause informational pamphlets under certain circumstances.
Designates October of each year as "Menopause Awareness Month," October 11 of each year as "Perimenopause Day," and October 18 of each year as "Postmenopause Day" in New Jersey.
Enacts the menopause awareness improvement act; establishes a menopause education program; establishes course work or training in menopausal health; directs the commissioner of labor to conduct a study on the impact of menopause on the workforce.